Resources for people with ILD
Support patients with ILD: identify early, diagnose confidently, and treat promptly.
What I did:
Client: Boehringer-Ingelheim
Unbranded Project: https://www.lungsandyou.com/
Deliverables:
Website Design
(This is my ILD Story, Find a Pulmonologist, Homepage Quiz, Tune Into Lung Health with Bernie Williams, Chronic Lung Disease in Veteran, Are you at Risk for ILD)L&Y Facebook Social Posts and Facebook Ads
(Boehringer-Ingelheim is responsbile for this page)Digital Ad Banners
Project type and deliverables:
UX Design
UI Prototype (InVision)
Patient/ User Insights (BI Patient Research findings/ Hotjar Survey)
UI Design (Client: Sketch,
Wunderman Thompson: Figma)Product Owner
Background
Project
Support early diagnosis and prompt treatment of pulmonary fibrosis by increasing awareness and education of the broader ILD (interstitial lung disease) category.
Strengthen OFEV’s position in the market as the preferred treatment and leader in the ILD space.
Problem
Why do we need L&Y?
Patient Research Insights
Patient decline is invisible – and so is their role in management
Patients are unaware and uneducated about ILD, and so are their caregivers.
In the early stages, the symptoms and associated impacts are hidden by aging, and the progression is slow enough that it is not to be recognized until it is too late.
Problem
ILD is a rare disease
In the United States, a rare disease is defined by the Orphan Drug Act as a disease or condition that impacts fewer than 200,000 people.
(In other words, 60 per 100,000 individuals)
~55%
of people with ILD, including IPF, reported at least one misdiagnosis
~ 14% were initially misdiagnosed with asthma
~ 13% with pneumonia
~ 12% with bronchitis
~ 10% with allergies
~ 7% with chronic obstructive pulmonary disease (COPD)
Patient Research Insights
Background
What is ILD?
ILD (interstitial lung disease) is an umbrella term for a group of 200+ disorders that cause fibrosis in the lung interstitium.
(A space in the lungs where lung tissue comes into contact with the immune system, blood vessels, nerves, or elastic and connective tissues)
Terminology for Clinical Trials:
Fibrosis = Scarring
Chronic = Long-Lasting
Progressive = Worsening = Progression
How Might We Statement
"How might we develop more effective, accessible diagnostic tools and treatment options for individuals with interstitial lung disease (ILD) to early detection, improve patient outcomes, and ultimately enhance their quality of life?"
What I did for this project
Solution
As a user experience designer, I led the designs for understanding the patient journey from early diagnosis to disease management via various campaigns through different media platforms.
Lungs and You Website
OFEV Website
Email Streams
Web Advertisements
-
-
Boehringer Ingelheim USA Corporation is responsible for this Page.
Impact
Site visits increased 46% YoY, driven by a 60% increase in paid media traffic (display, search, and social), garnering 48% of total site visits (235K) and increasing site visits by 88K YoY
Contact me to learn more about the uniqueness of working in the heavily regulated Health and Wellness industry that impacts the Direct-to-Consumer Advertising business.